1 / 1

Bipolar Depression Market

In 2017, the total diagnosed prevalent population of Bipolar Depression in 7MM was 1,857,545. The diagnosed prevalence of Bipolar Depression in the United States was found to be 740,715 in 2017.<br><br>The market size of Bipolar Depression in the seven major markets was USD 762.83 million in 2017.<br><br>Novel insights into disease, improvement in treatment over the years, increasing adherence to treatment, and increase in awareness and advancements in the technology are some of the key factors expected to drive the Bipolar Depression Market forward in the coming years. <br><br>Some of the key players in the Bipolar Depression market includes Otsuka Pharmaceutical, Intra-cellular Therapies, NeuroRx, COMPASS Pathways, Sage Therapeutics, Sunovion/Sumitomo Dainippon Pharma, Iltoo Pharma, Celon Pharma, and many others.<br><br>For more details on Bipolar Depression market, visit: <br>https://www.delveinsight.com/report-store/bipolar-disorder-manic-depression-market<br><br>

DelveInsight
Download Presentation

Bipolar Depression Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

    More Related